glp-1-based therapy Q&A: Long-term success of GLP-1 therapies hinges on more than just a prescription While there is a lot
Description
It is well established that patients with diabetes demonstrate higher susceptibility to pancreatic cancer and pancreatitis compared to non-diabetic individuals, and theoretically, sustained GLP-1 receptor activation induced by GLP-1RA therapy may potentially elevate pancreatic cancer risk [8]
Semaglutide is a GLP-1 medication that helps reduce appetite and supports weight loss under medical supervision.

Gudin B, Ladhari C, Robin P, Laroche ML, Babai S, Hillaire-Buys D, Faillie JL

Shandong Suncadia Medicine (Subsidiary of Jiangsu Hengrui Pharmaceutical) HRS-7535 [58] [58] In a Phase 1 clinical trial conducted by Shandong Suncadia Medicine, a subsidiary of Jiangsu Hengrui Pharmaceutical, the GLP1R agonist HRS-7535 was investigated

That is why eye doctors and diabetes doctors should work together instead of treating the retina and blood sugar as separate issues

natural flavorings
